92 related articles for article (PubMed ID: 15062521)
1. The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Farray D; Carman TL; Fernandez BB
Neurol Clin; 2004 May; 22(2):423-39. PubMed ID: 15062521
[TBL] [Abstract][Full Text] [Related]
2. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group.
Comp PC; Voegeli T; McCutchen JW; Skoutakis VA; Trowbridge A; Overdyke WL
Orthopedics; 1998 Oct; 21(10):1123-8. PubMed ID: 9801236
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic options in DVT prophylaxis.
Wille-Jørgensen P
Orthopedics; 2000 Jun; 23(6 Suppl):s639-42. PubMed ID: 10875428
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
Wade WE
Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
[TBL] [Abstract][Full Text] [Related]
5. Ardeparin and danaparoid.
Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
[No Abstract] [Full Text] [Related]
6. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
[TBL] [Abstract][Full Text] [Related]
7. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
Fischer KG
Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
[No Abstract] [Full Text] [Related]
8. Danaparoid in the prevention of thromboembolic complications.
Skoutakis VA
Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
[TBL] [Abstract][Full Text] [Related]
9. Safe anticoagulation with danaparoid in pregnancy and lactation.
Schindewolf M; Mosch G; Bauersachs RM; Lindhoff-Last E
Thromb Haemost; 2004 Jul; 92(1):211. PubMed ID: 15213864
[No Abstract] [Full Text] [Related]
10. Vascular drugs in the new millennium.
Frangos SG; Chen AH; Sumpio B
J Am Coll Surg; 2000 Jul; 191(1):76-92. PubMed ID: 10898187
[No Abstract] [Full Text] [Related]
11. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
12. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
Boneu B
Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Lindhoff-Last E; Bauersachs R
Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
[TBL] [Abstract][Full Text] [Related]
14. Portal vein thrombosis treated using danaparoid sodium and antithrombin III.
Uchiyama T; Hirokazu T; Hosono K; Endo H; Akiyama T; Yoneda K; Inamori M; Abe Y; Kubota K; Saito S; Nakajima A
Hepatogastroenterology; 2010; 57(97):52-3. PubMed ID: 20422871
[TBL] [Abstract][Full Text] [Related]
15. Ardeparin and danaparoid for prevention of deep vein thrombosis.
Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
[No Abstract] [Full Text] [Related]
16. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
18. Limitations of conventional treatment options for heparin-induced thrombocytopenia.
Warkentin TE
Semin Hematol; 1998 Oct; 35(4 Suppl 5):17-25; discussion 35-6. PubMed ID: 9855180
[TBL] [Abstract][Full Text] [Related]
19. Options to heparin anticoagulation for cardiac interventions.
Kahn JK
Catheter Cardiovasc Interv; 1999 Mar; 46(3):356. PubMed ID: 10348140
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
